1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Diagnosis, prognosis and risk assessment of multiple myeloma: Identifying gaps and addressing education needs for hematologists and oncologists
    Meeting Abstract

    Van Laar, E.; Fagerlie, S.; Landgren, O.
    Haematologica (2016)

    Fulltext@MSK | Save
  • Patterns of idelalisib treatment-emergent lymphocytosis in patients with CLL or SLL
    Meeting Abstract

    Ghia, P.; Cheson, B. D.; Furman, R. R.; Hallek, M.; Hillmen, P.; O'Brien, S. M.; Sharman, J. P.; Dubowy, R. L.; Velasco, B.; Waldapfel, C. C.; more...
    Haematologica (2016)

    Fulltext@MSK | Save
  • Comparison of pace clinical trial vs real-world ponatinib prescribing and duration of therapy in chronic-phase chronic myeloid leukemia (CP-CML) patients
    Meeting Abstract

    Mauro, M.; McGarry, L. J.; Yang, M.; Lustgarten, S.; Huang, H.
    Haematologica (2016)

    Fulltext@MSK | Save
  • Preliminary findings from a chart review of lower dosing of ponatinib in chronic myeloid leukemia (CML) patients
    Meeting Abstract

    Mauro, M.; McGarry, L.; Inguilizian, A.; du Moulin, R.; Huang, H.
    Haematologica (2016)

    Fulltext@MSK | Save
  • NEOD001 demonstrates cardiac responses in patients with light chain amyloidosis and persistent organ dysfunction in a phase 1/2 study expansion
    Meeting Abstract

    Liedtke, M.; Comenzo, R. L.; Landau, H.; Sanchorawala, V.; Weiss, B.; Zonder, J.; Walling, J.; Kinney, G. G.; Koller, M.; Schenk, D. B.; more...
    Journal of Cardiac Failure (2016)

    Fulltext@MSK | Save
  • Dietary habits across the lifespan and risk of monoclonal gammopathy of undetermined significance: A population based screening study
    Meeting Abstract

    Thordardottir, M.; Lindqvist, E.; Lund, S.; Costello, R.; Torfadottir, J.; Burton, D.; Steingrimsdottir, L.; Korde, N.; Mailankody, S.; Eiriksdottir, G.; more...
    Haematologica (2016)

    Fulltext@MSK | Save
  • Phase 1 final results and phase 2a dose selection for cerdulatinib (Prt062070) a dual SYK/JAK inhibitor in patients with relapsed/refractory B cell malignancies
    Meeting Abstract

    Hamlin, P.; Flinn, I.; Wagner-Johnston, N.; Burger, J.; Michelson, G.; Pandey, A.; Birrell, M.; Coffey, G.; Leeds, J.; Sabalvaro-Torres, A.; more...
    Haematologica (2016)

    Fulltext@MSK | Save
  • Survival in chronic lymphocytic leukemia: A population-based study including 13,034 patients diagnosed in 1982-2013 in Sweden
    Meeting Abstract

    Steingr-Msson, V.; Lund, S. H.; Dickman, P. W.; Weibull, C.; Bjorkholm, M.; Landgren, O.; Kristinsson, S. Y.
    Haematologica (2016)

    Fulltext@MSK | Save
  • Phase 1b study of pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma: Keynote-013
    Meeting Abstract

    Zinzani, P. L.; Ribrag, V.; Moskowitz, C. H.; Michot, J. M.; Kuruvilla, J.; Balakumaran, A.; Thompson, S.; Marinello, P.; Chlosta, S.; Shipp, M. A.; more...
    Haematologica (2016)

    Fulltext@MSK | Save
  • Characteristics of ponatinib therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) patients in real-world clinical practice compared to the pace trial
    Meeting Abstract

    Mauro, M.; McGarry, L. J.; Yang, M.; Lustgarten, S.; Huang, H.
    Haematologica (2016)

    Fulltext@MSK | Save